Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Victoria Ceccaroni is an accomplished AI Scientist with a strong background in applying machine learning, particularly graph neural networks and deep learning, to drug discovery and computational biology. She currently holds the position of Senior AI Scientist at GSK, where she focuses on leveraging AI to accelerate the development of new medicines. Prior to GSK, Victoria was a Research Scientist at BenevolentAI, contributing to their AI-driven drug discovery platform. She earned her PhD from the University of Cambridge, where her research centered on developing novel machine learning methods for biological network analysis and drug repurposing. Victoria is passionate about the intersection of artificial intelligence and life sciences, aiming to translate complex biological data into actionable insights for therapeutic innovation.
Victoria Ceccaroni's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
Currently driving AI initiatives in drug discovery at GSK, focusing on the development and application of advanced machine learning models to identify novel therapeutic targets and accelerate preclinical research.
Completed doctoral research at the University of Cambridge, specializing in graph machine learning and its applications in computational biology, particularly for drug repurposing and understanding disease mechanisms. Her work often involved developing novel algorithms for biological network analysis.
As a Research Scientist at BenevolentAI, contributed to the development of their AI platform by designing and implementing machine learning models that analyze vast biomedical datasets to identify potential new drugs and therapies.
Authored and co-authored several research papers in peer-reviewed journals and presented findings at leading international conferences in the fields of artificial intelligence, machine learning, and computational biology.
42 - Year 2021
Synthesis- Entrepreneurship & Innovation Learning - Year 2024
Hook - Year 2022
SIOI - Società Italiana per l'Organizzazione Internazionale - Year 2020
University of Leeds - Year 2016
Liceo San Giuseppe Calasanzio di Roma - Year 2011
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Welyk is an AI-powered communication and collaboration platform designed to centralize information, streamline workflows, and enhance team productivity. It aims to be an intelligent hub that connects various tools and communication channels, offering features like smart search, task management, and integrated messaging to help businesses operate more efficiently.
Get verified emails, phone numbers, and LinkedIn profile details
Discover contacts with similar roles, seniority, or companies
Uncover insights like skills, work history, social links, and more
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.